Form 4: Standard BioTools Director Acquires Shares Through Restricted Stock Units

Director Troy Cox acquired 62,910 shares of Standard BioTools Inc. through Restricted Stock Units (RSUs) in lieu of cash compensation.

Summary

• On February 28, 2025, Troy Cox, a director of Standard BioTools Inc., acquired 62,910 shares of common stock through Restricted Stock Units (RSUs).
• The RSUs were granted in lieu of $67,000 in cash compensation for his services as a board member.
• The price per share was $1.065.
• The RSUs vest as to 25% on the last day of the last month of each fiscal quarter of 2025, contingent upon continued service.
• Following the transaction, Mr. Cox directly owns 224,730 shares of Standard BioTools Inc.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine transaction of a director receiving equity compensation. It doesn't inherently indicate positive or negative performance, but rather aligns the director's interests with shareholders.

Positives

• A director's decision to take compensation in the form of company stock may signal confidence in the company's future performance.

Future Outlook

The RSUs vest quarterly throughout 2025, contingent on continued service, suggesting an ongoing commitment from the director.

Industry Context

This type of equity compensation is common for board members and executives, aligning their interests with those of shareholders.

Stakeholder Impact

• The transaction increases the director's stake in the company, aligning his interests with those of other shareholders.

Key Dates